Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies

Placenta

Volumn 25, Issue 2-3, 2004, Pages 127-139

  Mayhew, Terry M ^a   Charnock Jones, D S ^b   Kaufmann, P ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; ANGIOPOIETIN; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; ENDOSTATIN; ERYTHROPOIETIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; VASCULOTROPIN;

ALTITUDE; ANGIOGENESIS; CIGARETTE SMOKING; DIABETES MELLITUS; ENDOTHELIUM CELL; FETOPLACENTAL UNIT; FETUS; FETUS HYPOXIA; HUMAN; INTRAUTERINE GROWTH RETARDATION; MOLECULAR MECHANICS; MORPHOMETRICS; PERICYTE; PLACENTA CIRCULATION; PLACENTA VILLUS; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; UMBILICAL CORD BLOOD FLOW;

EID: 1342344900     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2003.10.010     Document Type: Review

References (160)

1. Charnock-Jones DS, Kautmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004;25:103-13.
2. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 2004;25:114-26.
3. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000;92:35-43.
4. Larsen LG, Clausen HV, Jonsson L. Stereologic examination of placentas from mothers who smoke during pregnancy. Am J Obstet Gynecol 2002;186:531-7.
5. Mayhew TM, Bowles C, Yücel F. Hypobaric hypoxia and villous trophoblast: evidence that human pregnancy at high altitude (3600 m) perturbs epithelial turnover and coagulation-fibrinolysis in the intervillous space. Placenta 2002;23:154-62.
6. Kingdom JCP, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997;18:613-21.
7. Clark DE, Smith SK, Sharkey AM, Charnock-Jones DS. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy, Hum Reprod 1996;11:1090-8.
8. Clark DE, Smith SK, Licence D, Evans AL, Charnock-Jones DS. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 1998;159:459-67.
9. Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (P1GF) and soluble Flt-1 by oxygen - a review. Placenta 2000;21(suppl A, Troph Res, 14):S16-24.
10. Wu P, Yonekura H, Li H, Nozaki I, Tomono Y, Naito I et al. Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes. Biochem Biophys Res Commun 2001; 288:1149-34.
11. Kaufmann P, Bruns U, Leiser R, Luckhardt M, Winterhager E. The fetal vascularisation of term human placental villi. II. Intermediate and terminal villi. Anat Embryol 1985;173:203-14.
12. Kaufmann P, Luckhardt M, Leiser R. Three-dimensional representation of the fetal vessel system in the human placenta. Trophoblast Res 1988; 3:113-37.
13. Benirschke K, Kaufmann P. Pathology of the human placenta. 4th ed New York: Springer Verlag, 2000 947 pp.
14. Castellucci M, Kosanke G, Verdenelli F, Huppertz B, Kaufmann P. Villous sprouting: fundamental mechanisms of human placental development. Hum Reprod Update 2000;6:485-94.
15. Mayhew TM. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. Placenta 2002;23:742-50.
16. Kaufmann P, Kingdom J. Development of the vascular system in the placenta. In: Risau W, Rubanyi GM, editors. Morphogenesis of endothelium. Amsterdam: Harwood Academic Publishers; 2000, p. 255-75.
17. Lash G, Taylor CM, Trew AJ, Cooper S, Anthony FW, Wheeler T et al. Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors 2002;20:189-96.
18. Trollmann R, Amann K, Schoof E, Beinder E, Wenzel D, Rascher W et al. Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia. Am J Obstet Gynecol 2003;188:517-23.
19. Caro J, Erslev AJ, Silver R, Miller O, Birgegard G. Erythropoietin production in response to anemia or hypoxia in the newborn rat. Blood 1982; 60: 984-8.
20. Costa-Giomi P, Caro J, Weinmann R. Enhancement by hypoxia of human erythropoietin gene transcription in vitro. J Biol Chem 1990; 265:10185-8.
21. Moritz KM, Cooper E, Wintour EM. The effect of haemorrhage on erythropoietin concertration in the mature ovine fetus. J Dev Physiol 1992;17:157-61.
22. Ballew C, Haas JD. Hematologic evidence of fetal hypoxia among newborn infants at high altitude in Bolivia. Am J Obstet Gynecol 1986; 155:166-9.
23. Snijders RJ, Abbas A, Melby O, Ireland RM, Nicolaides KH. Fetal plasma erythropoietin concentration in severe growth retardation. Am J Obstet Gynecol 1993;168:615-9.
24. Mamopoulos M, Bili H, Tsantali C, Assimakopoulos E, Mantalenakis S, Farmakides G. Erythropoietin umbilical serum levels during labor in women with preeclampsia, diabetes, and preterm labor. Am J Perinatol 1994;11:427-9.
25. Gruslin A, Perkins SL, Manchanda R, Fleming N, Clinch JJ. Maternal smoking and fetal erythropoietin levels. Obstet Gynecol 2000;95:561-4.
26. Erdem A, Erdem M, Arslan M, Yazici G, Eskandari R, Himmetoglu O. The effect of maternal anemia and iron deficiency on fetal erythropoiesis: comparison between serum erythropoietin, hemoglobin and ferritin levels in mothers and newborns. J Matern Fetal Neonatal Med 2002;11:329-32.
27. Habek D, Habek JC, Ivaniševic M, Djelmiš J. Fetal tobacco syndrome and perinatal outcome. Fetal Diagn Ther 2002;17:367-71.
28. Dunst J, Pigorsch S, Hansgen G, Hintner I, Lautenschlager C, Becker A. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis? Strahlenther Onkol 1999;175:93-6.
29. Lewis RM, James LA, Zhang J, Byrne CD, Hales CN. Effects of maternal iron restriction in the rat on hypoxia induced gene expression and fetal metabolite levels. Br J Nutr 2001;85:193-201.
30. Kadyrov M, Kosanke G, Kingdom J, Kaufmann P. Increased fetoplacental angiogenesis during first trimester in anaemic women. Lancet 1998;352:1747-9.
31. Reshetnikova OS, Burtun GJ, Teleshova OV. Placental histomorphometry and morphometric diffusing capacity of the villous membrane in pregnancies complicated by maternal iron-deficiency anemia. Am J Obstet Gynecol 1995;173:724-7.
32. Burton GJ, Reshetnikova OS, Milovanov AP, Teleshova OV. Stereological evaluation of vascular adaptations in human placental villi to differing forms of hypoxic stress. Placenta 1996;17:49-55.
33. Huang A, Zhang R, Yang Z. Quantitative (stereological) study of placental structures in women with pregnancy iron-deficiency anemia. Eur J Obstet Gynecol Reprod Biol 2001;97:59-64.
34. Lewis RM, Doherty CB, James LA, Burton GJ, Hales CN. Effects of maternal iron restriction on placental vascularization in the rat. Placenta 2001;22:534-9.
35. Haas JD. Maternal adaptation and fetal growth at high altitude in Bolivia. In: Greene LS, Johnston FS, editors. Social and biological predictors of nutritional status, physical growth and neurological development. New York: Academic Press; 1980, p. 257-90.
36. Jackson MR, Gott P, Lye SJ, Knox Ritchie JW, Clapp JF. The effects of maternal aerobic exercise on human placental development: placental volumetric composition and surface areas. Placenta 1995a;16:179-91.
37. Clapp JF, Kim H, Burciu B, Schmidt S, Petry K, Lopez RN. Continuing regular exercise during pregnancy: effect of exercise volume on fetoplacental growth. Am J Obstet Gynecol 2002;186:142-7.
38. Mayhew TM. Changes in fetal capillaries during preplacental hypoxia: growth, shape remodelling and villous capillarization in placentas from high-altitude pregnancies. Placenta 2003;24:191-8.
39. Zamudio S, Wheeler T, Anthony FW, Moore LG. Vascular endothelial growth factor (VEGF), vascular resistance and villous angiogenesis at high altitude (3100 m). J Soc Gynecol Investig 2002;9(suppl):141A.
40. Conklin BS, Zhong D-S, Zhao W, Lin PH, Chen C. Shear stress regulates occludin and VEGF expression in porcine arterial endothelial cells. J Surg Res 2002b;102:13-21.
41. Ukropec JA, Hollinger MK, Woolkalis MJ. Regulation of VE-cadherin linkage to the cytoskeleton in endothelial cells exposed to fluid shear stress. Exp Cell Res 2002;273:240-7.
42. Walter R, Maggiorini M, Scherrer U, Contesse J, Reinhart WH. Effects of high-altitude exposure on vascular endothelial growth factor levels in man. Eur J Appl Physiol 2001;85:113-7.
43. Wheeler T, Anthony FW, Young DA, Moore LG, Zamudio S. Maternal circulating vascular endothelial growth factor (VEGF) is elevated in high altitude pregnancy. J Soc Gynecol Investig 2002;9(suppl):301A.
44. Ali KZM, Burton GJ, Morad N, Ali ME. Does hypercapillarization influence the branching pattern of terminal villi in the human placenta at high altitude? Placenta 1996;17:677-82.
45. Reshetnikova OS, Burton GJ, Milovanov AP. Effects of hypobaric hypoxia on the fetoplacental unit: the morphometric diffusing capacity of the villous membrane at high altitude. Am J Obstet Gynecol 1994; 171:1560-5.
46. Espinoza J, Sebire NJ, McAuliffe F, Krampl E, Nicolaides KH. Placental villus morphology in relation to maternal hypoxia at high altitude. Placenta 2001 ;22:606-8.
47. Zhang EG, Burton GJ, Smith SK, Charnock-Jones DS. Placental vessel adaptation during gestation and to high altitude: changes in diameter and perivascular cell coverage. Placenta 2002;23:751-62.
48. Jackson MR, Mayhew TM, Haas JD. The volumetric composition of human term placentae: altitudinal, ethnic and sex differences in Bolivia. J Anat 1987;152:173-87.
49. Jackson MR, Mayhew TM, Haas JD. Morphometric studies on villi in human term placentae and the effects of altitude, ethnic grouping and sex of newborn. Placenta 1987;8:487-95.
50. Bacon BJ, Gilbert RD, Kaufmann P, Smith AD, Trevino FT, Longo LD. Placental anatomy and diffusing capacity in guinea pigs following long-term maternal hypoxia. Placenta 1984;5:475-88.
51. Scheffen I, Kaufmann P, Philippens L, Leiser R, Geisen C, Mottaghy K. Alterations of the fetal capillary bed in the guinea pig placenta following long-term hypoxia. Adv Exp Med Biol 1990;277:779-90.
52. Krebs C, Longo LD, Leiser R. Term ovine placental vasculature: comparison of sea level and high altitude conditions by corrosion cast and histomorphometry. Placenta 1997;18:43-51.
53. Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ. Hypoxiareoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 2002; 28:1274-81.
54. Mandriota SJ, Pepper MS. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 1998;83:852-9.
55. Oh H, Takagi H, Suzuma K, Otami A, Matsumura M, Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999;274:15732-9.
56. Zhang EG, Smith SK, Baker PN, Charnock-Jones DS. The regulation and localization of angiopoietin-1, -2, and their receptor Tie-2 in normal and pathologic human placentae. Mol Med 2001;7:624-35.
57. Rajakumar A, Whitelock KA, Weissfeld LA, Daftary AR, Markovic N, Conrad KP. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod 2001;64:499-506 Erratum 64:1019-1020.
58. Rajakumar A, Doty K, Daftary A, Harger G, Conrad KP. Impaired oxygen-dependent reduction of HIF-1a and 2a proteins in pre-eclamptic placentae. Placenta 2003;24:199-208.
59. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W, Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999;94:1561-7.
60. Torry DS, Mukherjea D, Arroyo J, Torry RJ. Expression and function of placenta growth factor: implications for abnormal placentation. J Soc Gynecol Investig 2003;10:178-88.
61. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001;47:617-23.
62. Webb N J, Bottomley MJ, Watson CJ, Brenchley PE. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 1998;94:395-404.
63. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995;86:815-21.
64. Sharkey AM, Cooper JC, Balmforth JR, McLaren J, Clark DE, Charnock-Jones DS et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest 1996;26:1182-5.
65. Brockelsby JC, Wheeler T, Anthony FW, Wellings R, Baker PN. Increased circulating levels of vascular endothelial growth factor in preeclampsia. Hypertens Pregnancy 1998;17:283-90.
66. Hunter A, Aitkenhead M, Caldwell C, McCracken G, Wilson D, McClure N. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 2000;36:965-9.
67. El-Salahy EM, Ahmed MI, El-Gharieb A, Tawfik H. New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females. Clin Biochem 2001;34:323-9.
68. Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1999; 106:1019-22.
69. Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, Sibai BM. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 2000; 183:1554-7.
70. Kupferminc MJ, Daniel Y, Englender T, Baram A, Many A, Jaffa AJ et al. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol 1997;38:302-6.
71. Bosio PM, Wheeler T, Anthony F, Conroy R, O'Herlihy C, McKenna P. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol 2001;184:146-52.
72. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1996;103:1191-6.
73. Lyall F, Young A, Boswell F, Kingdom JC, Greer IA. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997; 18:269-76.
74. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Halmesmaki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 2001;7:205-10.
75. Ranheim T, Staff AC, Henriksen T. VEGF mRNA is unaltered in decidual and placental tissues in preeclampsia at delivery. Acta Obstet Gynecol Scand 2001;80:93-8.
76. Lash G, MacPherson A, Liu D, Smith D, Charnock-Jones S, Baker P. Abnormal fetal growth is not associated with altered chorionic villous expression of vascular endothelial growth factor mRNA. Mol Hum Reprod 2001;7:1093-8.
77. Tse JY, Lao TT, Chan CC, Chiu PM, Cheung AN. Expression of vascular endothelial growth factor in third-trimester placentas is not increased in growth-restricted fetuses. J Soc Gynecol Investig 2001; 8:77-82.
78. Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002;87:4213-24.
79. Kumazaki K, Nakayama M, Suehara N, Wada Y. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum Pathol 2002;33:1069-77.
80. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T et al. Vascular endothelial growth factor ligands and receptors that regulate cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002;160:1405-23.
81. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998;179:1539-44.
82. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnuck-Jones DS et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002;187:127-36.
83. Cho GJ, Roh GS, Kim HJ, Kim YS, Cho SH, Choi WJ et al. Differential expression of placenta growth factors and their receptors in the normal and pregnancy-induced hypertensive human placentas. J Korean Med Sci 2003;18:402-8.
84. Su YN, Lee CN, Cheng WF, Shau WY, Chow SN, Hsieh FJ. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 2001;97:898 904.
85. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001; 184:1267-72.
86. Tjoa ML, Van Vugt JM, Mulders MA, Schutgens RB, Oudejans CB, Van Wijk IJ. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 2001;98:600-7.
87. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188:177-82.
88. Livingston JC, Haddad B, Gorski LA, Neblett P, Ahokas RA, Ramsey R et al. Placenta growth factor is not an early marker for the development of severe preeclampsia. Am J Obstet Gynecol 2001;184:1218-20.
89. Charnock-Jones DS. Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature. J Anat 2002;200:607-15.
90. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003;88:2348-51.
91. Maynard SE, Min J-Y, Merchan J, Lim K H, Li J, Mondal S et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.
92. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 2003;24:219-26.
93. Hill DJ, Tevaarwerk GJ, Arany E, Kilkenny D, Gregory M, Langford KS et al. Fibroblast growth factor 2 (FGF-2) is present in maternal and cord serum, and in the mother is associated with a binding protein immunologically related to the FGF receptor-1. J Clin Endocrinol Metab 1995;80:1822-31.
94. Hohlagschwandtner M, Knofler M, Ploner M, Zeisler H, Joura EA, Husslein P. Basic fibroblast growth factor and hypertensive disorders in pregnancy. Hypertens Pregnancy 2002;21:235-41.
95. Kurz C, Hefler L, Zeisler H, Schatten C, Husslein P, Tempfer C. Maternal basic fibroblast growth factor serum levels are associated with pregnancy-induced hypertension. J Soc Gynecol Investig 2001;8:24-6.
96. Rajeshekhar G, Loganath A, Roy AC, Wong YC. Expression and localization of angiogenin in placenta: enhanced levels at term over first trimester villi. Mol Reprod Dev 2002;62:159-66.]
97. Rajeshekhar G, Loganath A, Roy AC, Wong YC. Over-expression and secretion of angiogenin in intrauterine growth retardation placenta. Mol Reprod Dev 2003;64:397-404.
98. Kolben M, Bläser J, Ulm K, Schmitt M, Schneider KTM, Tschesche H et al. Angiogenin plasma levels during pregnancy. Am J Obstet Gynecol 1997;176:37-41.
99. Yamashiro C, Ohnishi Y, Kanenishi K, Hayashi K, Yanagihara T, Hata T. Maternal and fetal circulating angiogenin levels in pregnancies with small-for-gestational age and appropriate-for-gestational age infants. Gynecol Obstet Invest 2000;49:156-9.
100. Todros T, Sciarrone A, Piccoli E, Guiot C, Kaufmann P, Kingdom J. Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. Obstet Gynecol 1999;93:499-503.
101. Boyd PA, Scott A. Quantitative structural studies on human placentas associated with pre-eclampsia, essential hypertension and intrauterine growth retardation. Br J Obstet Gynaecol 1985;92:714-21.
102. Teasdale F. Histomorphometry of the human placenta in maternal preeclampsia. Am J Obstet Gynecol 1985;152:25-31.
103. Sagol S, Sagol O, Ozdemir N. Stereological quantification of placental villus vascularization and its relation to umbilical artery Doppler flow in intrauterine growth restriction. Prenat Diagn 2002;22:398-403.
104. Teasdale F. Idiopathic intrauterine growth retardation: histomorphometry of the human placenta. Placenta 1984;5:83-92.
105. Pivalizza PJ, Woods DL, Sinclair-Smith CC, Kaschula ROC, Pivalizza EG. Placentae of light for dates infants born to underweight mothers at term: a morphometric study. Placenta 1990;11:135-42.
106. Macara LM, Kingdom JCP, Kaufmann P, Kohnen G, Hair J, More IAR et al. Structural analysis of placental terminal villi from growth restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996;17:37-48.
107. Ahmed A, Kilby MD. Commentary: Hypoxia or hyperoxia in placental insufficiency? Lancet 1997;350:826-7.
108. 2 diffusion and placental expression of P1GF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction. J Physiol 2003; 550:641-56.
109. Mai X, Zhuang Y, Lu H. Vascular endothelial growth factor expression in placenta from intrauterine growth retardation fetus with abnormal umbilical artery flow velocity waveforms. Zhonghua Fu Chan Ke Za Zhi 2000;35:606-9.
110. Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest 1999;79:151-70.
111. Dunk C, Shams M, Nijjar S, Rhaman M, Qiu Y, Bussolati B et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 2000;156:2185-99.
112. Macara L, Kingdom JCP, Kohnen G, Bowman AW, Greer IA, Kaufmann P. Elaboration of stem villous vessels in growth restricted pregnancies with abnormal umbilical artery Doppler waveforms. Br J Obstet Gynaecol 1995;102:807-12.
113. Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA, Kingdom JCP. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 1996;175:1534-42.
114. Chen C-P, Bajoria R, Aplin JD. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol 2002;187:764-9.
115. Mitra SC, Seshan SV, Riachi LE. Placental vessel morphometry in growth retardation and increased resistance of the umbilical artery Doppler flow. J Matern Fetal Neonatal Med 2000;9:282-6.
116. Jackson MR, Walsh AJ, Morrow RJ, Mullen JB, Lye SJ, Ritchie JW. Reduced placental villous tree elaboration in small-for-gestational-age pregnancies: relationship with umbilical artery Doppler waveforms. Am J Obstet Gynecol 1995b;172:518-25.
117. Biagiotti R, Sgambati E, Brizzi E. Placental morphometry in pregnancies complicated by intrauterine growth retardation with absent or reversed end diastolic flow in the umbilical artery. Ital J Anat Embryol 1999;104:201-7.
118. Karsdorp VHM, Dirks BK, Van der Linden JC, Van Vugt JMG, Baak JPA, Van Geijn HP. Placenta morphology and absent or reversed end diastolic flow velocities in the umbilical artery: a clinical and morphometrical study. Placenta 1996;17:393-9.
119. Widness JA, Susa JB, Garcia JF, Singer DB, Seghal O, Oh W et al. Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic Rhesus fetuses. J Clin Invest 1981;67:637-42.
120. Mayhew TM, Sørensen FB, Klebe JG, Jackson MR. Oxygen diffusive conductances in placentae from control and diabetic women. Diabetologia 1993;36:955-60.
121. Mayhew TM, Sørensen FB, Klebe JG, Jackson MR. Growth and maturation of villi in placentae from well controlled diabetic women. Placenta 1994;15:57-65.
122. Kamal K, Du W, Mills I, Sumpio BE. Antiproliferative effects of elevated glucose in human microvascular endothelial cells. J Cell Biochem 1998;71:491-501.
123. Beltramo E, Pomero F, Allione A, D'Alú F, Ponte E, Porta M. Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high glucose concentrations. Diabetologia 2002;45:416-9.
124. Beltramo E, Buttiglieri S, Pomero F, Allione A, D'Alú F, Ponte E et al. A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose. Diabetologia 2003;46:409-15.
125. Okamoto T, Tanaka S, Stan AC, Koike T, Kase M, Makita Z et al. Advanced glycation end products induce angiogenesis in vivo. Microvasc Res 2002;63:186-95.
126. Hill DJ, Tevaarwerk GJ, Caddell C, Arany E, Kilkenny D, Gregory M. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size. J Clin Endocrinol Metab 1995;80:2626-32.
127. Hill DJ, Petrik J, Arany E. Growth factors and the regulation of fetal growth. Diabetes Care 1998;21(Suppl 2):B60-9.
128. Di Blasio AM, Carniti C, Vigano P, Florio P, Petraglia F, Vignali M. Basic fibroblast growth factor messenger ribonucleic acid levels in human placentas from normal and pathological pregnancies. Mol Hum Reprod 1997;3:1119-23.
129. Arany E, Hill DJ. Fibroblast growth factor-2 and fibroblast growth factor receptor-1 mRNA expression and peptide localization in placentae from normal and diabetic pregnancies. Placenta 1998;19:133-42.
130. Teasdale F. Histomorphometry of the human placenta in class B diabetes mellitus. Placenta 1983;4:1-12.
131. Teasdale F. Histomorphometry of the human placenta in class C diabetes mellitus. Placenta 1985;6:69-82.
132. Mayhew TM. Enhanced fetoplacental angiogenesis in pre-gestational diabetes mellitus: the extra growth is exclusively longitudinal and not accompanied by microvascular remodelling. Diabetologia 2002b; 45:1434-9.
133. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002;51:3107-12.
134. Jirkovská M, Kubínová L, Janácek J, Moravcová M, Krejí V, Karen P. Topological properties and spatial organization of villous capillaries in normal and diabetic placentas. J Vasc Res 2002;39:268-78.
135. Teasdale F. Histomorphometry of the placenta of the diabetic woman: class A diabetes mellitus. Placenta 1981;2:241-52.
136. Babawale MO, Lovat S, James DK, Mayhew TM, Leach L. Effect of gestational diabetes on junctional adhesion molecules in the human term placental vasculature. Diabetologia 2000;43:1185-96.
137. Bush PG, Mayhew TM, Abramovich DR, Aggett PJ, Burke MD, Page KR. A quantitative study on the effects of maternal smoking on placental morphology and cadmium concentration. Placenta 2000; 21:247-56.
138. Bush PG, Mayhew TM, Abramovich DR, Aggett PJ, Burke MD, Page KR. Maternal cigarette smoking and oxygen diffusion across the placenta. Placenta 2000;21:824-33.
139. Shiverick KT, Salafia C. Cigarette smoking and pregnancy I: Ovarian, uterine and placental effects. Placenta 1999;20:265-72.
140. Morrow RJ, Ritchie JW, Bull SB. Maternal cigarette smoking: the effects on umbilical and uterine blood flow velocity. Am J Obstet Gynecol 1988;159:1069-71.
141. Clausen HV, Jorgensen JC, Ottesen B. Stem villous arteries from the placentas of heavy smokers: functional and mechanical properties. Am J Obstet Gynecol 1999;180:476-82.
142. Hampl V, Bibova J, Stranak Z, Wu X, Michelakis ED, Hashimoto K et al. Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition. Am J Physiol Heart Circ Physiol 2002; 283:H2440-9.
143. Resch BE, Gaspar R, Sonkodi S, Falkay G. Vasoactive effects of erythropoietin on human placental blood vessels in vitro. Am J Obstet Gynecol 2003;188:993-6.
144. Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci 2000;57:207-13.
145. Conklin BS, Zhao W, Zhong DS, Chen C. Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol 2002a;160:413-8.
146. Villablanca AC. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 1998;84:2089-98.
147. 1 production in endothelial cells. Biochem Biophys Res Commun 1999;257:306-12.
148. Michaud S-É, Ménard C, Guy L-G, Gennaro G, Rivard A. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-la/VEGF pathway. FASEB J 2003;17:1150-2.
149. Pfarrer C, Macara L, Leiser R, Kingdom J. Adaptive angiogenesis in placentas of heavy smokers. Lancet 1999;354:303.
150. Burton GJ, Palmer ME, Dalton KJ. Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers. Br J Obstet Gynaecol 1989;96:907-15.
151. Teasdale F, Ghislaine JJ. Morphological changes in the placentas of smoking mothers: a histomorphometric study. Biol Neonate 1989; 55:251-9.
152. Guschmann M, Henrich W, Dudenhausen JW. Chorioangiomas - new insights into a well-known problem. II. An immuno-histochemical investigation of 136 cases. J Perinat Med 2003;31:170-5.
153. Noack F, Sotlar K, Thorns C, Smrcek J, Diedrich K, Feller AC et al. VEGF-, KIT protein and neural endopeptidase (NEP/CD10)-positive myofibroblasts - precursors of angiogenesis in chorioangiomas? Placenta 2003;24:758-66.
154. Choi H-K, Choi BC, Lee JW, Cha KY, Baek K-H. Expression of angiogenesis- and apoptosis related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev 2003;66:24-31.
155. Hindmarsh PC, Geary MPP, Rodeck CH, Jackson MR, Kingdom JCP. Effect of early maternal iron stores on placental weight and structure. Lancet 2000;356:719-23.
156. Khalid MEM, Ali ME, Ali KZM. Full-term birth weight and placental morphology at high and low altitude. Int J Gynaecol Obstet 1997; 57:259-65.
157. Björk O, Persson B. Placental changes in relation to the degree of metabolic control in diabetes mellitus. Placenta 1982;3:367-78.
158. Asmussen I. Ultrastructure of the human placenta at term. Observations on placentas from newborn children of smoking and non-smoking mothers. Acta Obstet Gynecol Scand 1977;56:119-26.
159. Asmussen I. Ultrastructure of the villi and fetal capillaries in placentas from smoking and nonsmoking mothers. Br J Obstet Gynaecol 1980; 87:239-45.
160. Van Der Velde WJ, Copius Peereboom-Stegeman JHJ, Treffers PE, James J. Structural changes in the placenta of smoking mothers: a quantitative study. Placenta 1983;4:231-40.